Shanghai Kehua Bio-engineering Co Ltd (002022):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Shanghai Kehua Bio-engineering Co Ltd (002022) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7320
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Shanghai Kehua Bio-engineering Co Ltd (KHB) is a medical device company that develops, manufactures and markets in vitro diagnostic devices and related products. The company’s major product portfolio includes enzyme immunoassay kits, clinical chemistry reagents, PCR kits, rapid test kits, chemiluminescence reagents; and laboratory instruments such as clinical chemistry analyzers, electrolyte analyzers, microplate readers, nucleic acid extractors and automatic chemiluminescence analyzers. It is one of the global suppliers of WHO, UNICEF, PEPFAR, and the Clinton HIV/AIDS Initiative. The company has sales supports facilities in major cities in China and it markets its products in China and across the world through distributors. KHB is headquartered in Shanghai, China.

Shanghai Kehua Bio-engineering Co Ltd (002022) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Shanghai Kehua Bio-engineering Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Shanghai Kehua Bio-engineering Co Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Shanghai Kehua Bio-engineering Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Shanghai Kehua Bio-engineering Co Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Shanghai Kehua Bio-engineering Co Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Shanghai Kehua Bio-engineering Co Ltd, Medical Equipment, Deal Details 10
Partnerships 10
Immunodiagnostic Systems Enters into Agreement with Technogenetics 10
Shanghai Kehua Bio-engineering to Form Joint Venture with Altergon Italia 11
Equity Offering 12
Shanghai Kehua Bio-Engineering Decreases Size of Private Placement of Shares for USD52 Million 12
Acquisition 13
Shanghai Kehua Plans to Acquire 26.6983% Stake in Suzhou Hybiome Biomedical Engineering for USD50.7 Million 13
KHB Shanghai Kehua Bio-Engineering Acquires Technogenetics USD20.6 Million 14
Shanghai Kehua to Acquire Technogentics from Bouty Healthcare 15
Shanghai Kehua Bio-engineering Co Ltd – Key Competitors 16
Shanghai Kehua Bio-engineering Co Ltd – Key Employees 17
Shanghai Kehua Bio-engineering Co Ltd – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Shanghai Kehua Bio-engineering Co Ltd, Medical Equipment, Key Facts, 2017 2
Shanghai Kehua Bio-engineering Co Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Shanghai Kehua Bio-engineering Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Shanghai Kehua Bio-engineering Co Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Shanghai Kehua Bio-engineering Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Shanghai Kehua Bio-engineering Co Ltd, Deals By Market, 2012 to YTD 2018 8
Shanghai Kehua Bio-engineering Co Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Immunodiagnostic Systems Enters into Agreement with Technogenetics 10
Shanghai Kehua Bio-engineering to Form Joint Venture with Altergon Italia 11
Shanghai Kehua Bio-Engineering Decreases Size of Private Placement of Shares for USD52 Million 12
Shanghai Kehua Plans to Acquire 26.6983% Stake in Suzhou Hybiome Biomedical Engineering for USD50.7 Million 13
KHB Shanghai Kehua Bio-Engineering Acquires Technogenetics USD20.6 Million 14
Shanghai Kehua to Acquire Technogentics from Bouty Healthcare 15
Shanghai Kehua Bio-engineering Co Ltd, Key Competitors 16
Shanghai Kehua Bio-engineering Co Ltd, Key Employees 17
Shanghai Kehua Bio-engineering Co Ltd, Subsidiaries 18

List of Figures
Shanghai Kehua Bio-engineering Co Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Shanghai Kehua Bio-engineering Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Shanghai Kehua Bio-engineering Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Shanghai Kehua Bio-engineering Co Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Shanghai Kehua Bio-engineering Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Shanghai Kehua Bio-engineering Co Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Shanghai Kehua Bio-engineering Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Shanghai Kehua Bio-engineering Co Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Shanghai Kehua Bio-engineering Co Ltd (002022):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • SRP Groupe SA (SRP):企業の財務・戦略的SWOT分析
    SRP Groupe SA (SRP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • BPS Direct LLC:企業の戦略・SWOT・財務分析
    BPS Direct LLC - Strategy, SWOT and Corporate Finance Report Summary BPS Direct LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Verizon Communications Inc (VZ):企業の財務・戦略的SWOT分析
    Verizon Communications Inc (VZ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Information Services International-Dentsu Ltd (4812):企業の財務・戦略的SWOT分析
    Information Services International-Dentsu Ltd (4812) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s k …
  • Berger Paints India Ltd (BERGEPAINT):企業の財務・戦略的SWOT分析
    Berger Paints India Ltd (BERGEPAINT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Ridley Corporation Ltd:企業の戦略・SWOT・財務分析
    Ridley Corporation Ltd - Strategy, SWOT and Corporate Finance Report Summary Ridley Corporation Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Centene Corp (CNC):製薬・医療:M&Aディール及び事業提携情報
    Summary Centene Corp (Centene) is a healthcare service provider that offers services to government sponsored healthcare programs with focus on under-insured and uninsured individuals. It provides health plans through Medicaid, Medicare and Health Insurance Marketplace contracts; and other health sol …
  • Calliditas Therapeutics AB-製薬・医療分野:企業M&A・提携分析
    Summary Calliditas Therapeutics AB (Calliditas), formerly, Pharmalink AB is a pharmaceutical company that identifies, develops and commercializes pharmaceutical products for niche indications. The company’s product pipeline includes Nefecon for IgA Nephritis that is under Phase II clinical trials; a …
  • Caspian Energy Inc. (CKZ.H)-石油・ガス分野:企業M&A・提携分析
    Summary Caspian Energy Inc. (Caspian) is an independent upstream oil and gas company that explores for and develops hydrocarbon reserves, and produces oil and gas. Caspian and its subsidiaries hold interests in Aral Petroleum Capital LLP, which holds an exclusive license which entitles it to explore …
  • Regulus Therapeutics Inc (RGLS):企業の財務・戦略的SWOT分析
    Summary Regulus Therapeutics Inc (Regulus Therapeutics) is a biopharmaceutical company that discovers and develops microRNA based therapeutics. The company provides single stranded oligonucleotides, which are chemically synthesized chains of nucleotides that are mirror images of specific target micr …
  • SRF Ltd (SRF):企業の財務・戦略的SWOT分析
    SRF Ltd (SRF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Banque de France:企業の戦略的SWOT分析
    Banque de France - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Euronav NV (EURN):企業の財務・戦略的SWOT分析
    Summary Euronav NV (Euronav) is a transportation and logistics company that offers shipping services. The company provides seaborne transportation, tanker shipping, proactive management, fleet composition and ship management services. It offers ship management services which includes technical servi …
  • BSN medical GmbH:医療機器:M&Aディール及び事業提携情報
    Summary BSN medical GmbH (BSN medical), a subsidiary of Essity Aktiebolag, is healthcare company specialized in compression therapy, wound care and othropedics. It manufactures and markets medical products for wound care and related vascular diseases and lumphology, and non-invasive orthopedic produ …
  • Huneed Technologies
    Huneed Technologies - Strategy, SWOT and Corporate Finance Report Summary Huneed Technologies - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Bandera Electric Cooperative Inc:企業の戦略的SWOT分析
    Bandera Electric Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • KPC Pharmaceuticals Inc (600422)-製薬・医療分野:企業M&A・提携分析
    Summary KPC Pharmaceuticals Inc (KPC), formerly Kunming Pharmaceutical Corp, a subsidiary of Holley Group Co Ltd, is a manufacturer of botanical drugs and other pharmaceutical products. The company offers panax notoginseng, gastrodine, artemether and botanical drugs. It also offers drugs such as xue …
  • BioView Ltd (BIOV):医療機器:M&Aディール及び事業提携情報
    Summary BioView Ltd (BioView) develops, manufactures and markets automated cell imaging and analysis solutions, which incorporate proprietary imaging, analysis and review technology. The technology provides automatic control of fully motorized fluorescent and bright-field microscopes fitted with hig …
  • Rosenergoatom Concern JSC:企業の戦略的SWOT分析
    Rosenergoatom Concern JSC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Rossiiskie Zheleznye Dorogi:企業の戦略・SWOT・財務情報
    Rossiiskie Zheleznye Dorogi - Strategy, SWOT and Corporate Finance Report Summary Rossiiskie Zheleznye Dorogi - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆